Tag: Stem Cell Research
StemCells Inc., a California-based biotech company announced that they will stop developing the potential treatment for spinal cord injury after a failed mid-stage clinical trial. The company stock went down to $3.03 per share at the start of the pre-market trade. StemCells reported that they still have $5.5 million in cash as of May 31, but they don’t have a liquidating distribution to their stockholders.
The company said that the amount that they can give to the shareholders depends on the liquid assets, any liabilities, and costs of the wind down.
Spinal cord injury (SCI) involves damage to the area that can cause an impairment of loss of muscle control, movement and sensation. Currently, patients with injury to the spinal cord are managed with physical therapy, occupation therapy and other rehabilitation methods to cope with the physical changes.
However, stem cell research may present a new approach to the management of this patient group, allowing for a potential improvement in the symptoms of the condition, such as incontinence, muscular control and sexual function.
Cape Town – The words “stem cell research and therapy” evoke a number of responses. In emotionally vulnerable patients, a sense of hope.
In scientists, a great deal of excitement about future prospects. In the case of legal experts and ethicists, a need to ensure that patient safety and a spirit of distributive justice are maintained. And in the minds of entrepreneurs, an opportunity to develop a profitable business.
Stem cells are the building blocks of our bodies.
When using this form of gene editing, Cedars-Sinai scientists can more efficiently insert reporter genes that glow when a stem cell turns into a specific cell of the body. 5 billion cells of the heart.
The team foresees their findings being implemented in the regrowth of cells lost during heart attack. And this might tremendously benefit the patients who undergo these kinds of procedures.
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions.
A new study appearing today in STEM CELLS Translational Medicine, designed to test how stem cell injections affect primates with spinal cord injury (SCI), showed the treatments significantly improved the animals’ motor function recovery and promoted faster healing, too. The researchers call their findings a step forward toward the goal of improving outcomes for humans with chronic SCI.
Previous research conducted by various groups had indicated stem cell treatments helped rats with SCI.
LOUISVILLE, Ky. (5/23/15) — More than a dozen leading basic scientists from around the nation and the world studying neurological function made presentations to 160 fellow researchers in Louisville Wednesday and Thursday.
The goal? To facilitate collaborations that will advance science leading to improved spinal cord and head injury rehabilitation.
Scientists from Sweden, Canada and the United States shared their latest neurotrauma research at the 21st Annual Kentucky Spinal Cord and Head Injury Research Trust Symposium.
This story starts in 1955, upon the death of Albert Einstein, when the pathologist charged with performing the famous scientist’s autopsy stole his brain.
Fast forward to the 1980s when a University of California, Berkeley scientist was studying parts of the stolen goods involved in complex thinking and discovered that the father of relativity had more of certain types of cells, called astrocytes, than other human brains studied.
Today, another 30 years later, scientists still don’t have a solid grasp on everything these cells do in the human nervous system, largely because they’re difficult to study.
Stem cells hold great promise as a means of repairing cells in conditions such as multiple sclerosis, stroke or injuries of the spinal cord because they have the ability to develop into almost any cell type. Now, new research shows that stem cell therapy can also work through a mechanism other than cell replacement.
In a study published today in Molecular Cell, a team of researchers led by the University of Cambridge has shown that stem cells “communicate” with cells by transferring molecules via fluid filled bags called vesicles, helping other cells to modify the damaging immune response around them.
It’s one of the latest efforts to remake tissue in the lab. The discovery could lead to more research into human development and disease progression.
Using stem cells, scientists have recreated the cells that form an embryo’s spinal cord, muscle and bone tissue. This will help researchers further study embryonic development and possibly, one day, disease progression.
Neuro-mesodermal progenitors (NMPs) — the particular cells that form the spinal cord, muscle and skeleton — begin their transformation once given the go-ahead by certain chemical signals in the body.
With help from the zebrafish, a team of Australian researchers has uncovered how hematopoietic stem cells (HSC) renew themselves, considered by many to be the ‘holy grail’ of stem cell research.
HSCs are a significant type of stem cell present in the blood and bone marrow. These are needed for the replenishment of the body’s supply of blood and immune cells. HSCs already play a part in transplants in patients with blood cancers such as leukemia and myeloma. The stem cells are also studied for their potential to transform into vital cells including muscle, bone, and blood vessels.